Curate Biosciences
Transformative Cell Processing for Next-Generation Therapies
At Curate Biosciences we see a future where patients, clinicians, innovators, and payors routinely embrace cell and gene therapies against intractable disease. We foresee a world in which life-saving therapies are readily accessible to all, earlier in the treatment protocol, with longer persistence, fewer side effects, and with a positive impact to healthcare economics.
To help make this future a reality, we focus on advancing our platform technology, Deterministic Cell Separation™, to deliver greater quantities of the highest quality cellular starting materials, faster and less costly, to the innovators, developers, and clinicians pushing the boundaries of the possible.
Our Team

Mike Grisham
Chief Executive Officer

Tony Ward
Chief Technology Officer

Jason Walsh
Chief Financial Officer

Gaurav Vij
Chief Business Officer

Joan Haab
Senior Vice President, Manufacturing and Supply Chain

Khushroo Gandhi
Vice President, Product Development and Manufacturing

Roberto Campos-González
Vice President, Biology

Alison Skelley
Senior Director, Engineering and IP Strategy

Deepa Patel
Director of Finance and Administration

Cole Jones
Marketing Manager

Yasna Behmardi
Senior Microfluidics Engineer

Laurissa Ouaguia
Staff Scientist

Rechea Christie
Quality Engineer
Scientific Advisory Board
Curt Civin, MD – Chairman
- University of Maryland School of Medicine – Professor of Pediatrics & Physiology, Director of Center for Stem Cell Biology & Regenerative Medicine, Associate Dean for Research
- Previously, 30+ years endowed Professor at Johns Hopkins School of Medicine
- Discovered CD34 stem antigen and Mab, expert in stem cell biology, leukemia, and cellular analysis
- Amherst College, ScD Hon 2001; Harvard Medical School, MD 1974; Amherst College, BA 1970
James Sturm, PhD
- Director, Princeton Institute for the Science and Technology of Materials, William and Edna Macaleer Professor of Engineering and Applied Science, Professor of Electrical Engineering, Princeton University
Harry Malech, MD
- Chief, Genetic Immunotherapy Section, NIH/NIAID
Michael Meagher, MD
- Vice President, Therapeutics Production and Quality, St. Jude’s Childrens Research Hospital
Djordje Atanackovic, MD
- Medical Director of the Fannie Angelos Cellular Therapeutics Laboratory and Director of Cellular and Vaccine Immunotherapy, University of Maryland School of Medicine Marlene & Stewart Greenebaum Comprehensive Cancer Center
Nancy Hardy, MD
- Medical Director, Cell Therapy & Graft Engineering; Associate Director, Blood & Marrow Transplantation Program; Medical Director for Cancer Center Quality & Safety – University of Maryland School of Medicine Marlene & Stewart Greenebaum Comprehensive Cancer Center
Philip Tagari
- Vice President, Research, Amgen Inc.